Orchid Pharma informs about disclosure

04 Mar 2023 Evaluate
In continuation to earlier letter dated July 16, 2022 with respect to the approval granted to Orchid-Bio Pharma (wholly owned subsidiary) by Competent Authority under the Production Linked Incentive (PLI) Scheme for manufacturing of product ‘7 ACA’, Orchid Pharma has informed that the Company and Orchid Bio Pharma has entered into a Memorandum of Understanding (MoU) with an overseas technology provider for in-licensing 7ACA technology.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

723.40 -16.85 (-2.28%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×